New Regulatory Thinking Is Needed For Ai-based Personalised Drug And Cell Therapies In Precision Oncology

This article discusses the recent advancements in using AI for precision oncology, specifically in the personalization of drug and cell therapies. It explores the potential benefits and challenges of using AI in therapy design and delivery, and the need for regulatory frameworks to adapt to these emerging technologies.